Chembond Chemicals Q4 FY26: A 24% ROCE Microcap quietly compounding under the radar

Section 1 — At a Glance

Chembond Chemicals Limited logged a quantitative milestone in its financial performance for the fiscal year ended March 31, 2026, closing the year with an annual consolidated revenue from operations of ₹326.15 crore, up 11.6% from ₹292.27 crore in FY25. The bottom-line performance followed a parallel upward trajectory, with consolidated Net Profit expanding to ₹34.96 crore from ₹31.04 crore in the preceding fiscal year. This structural growth comes on the heels of a massive corporate layout cleanup—the National Company Law Tribunal (NCLT) approved composite scheme of arrangement which merged and demerged entities to streamline the core operations into the current listed form.

Investors tracking the asset are heavily focusing on its operational efficiency metrics, highlighted by an impressive Return on Capital Employed (ROCE) of 24.0%. Furthermore, a strong quarterly momentum acts as a primary catalyst, where Q4 FY26 revenue reached a record ₹101.38 crore, yielding a quarterly Net Profit of ₹11.73 crore.

However, beneath this clean operational exterior lie distinct variables that require structural caution. The company’s growth remains deeply concentrated in its core business, making its non-water verticals minor statistical outliers. Simultaneously, the working capital architecture is stretching out, with cash conversion cycles hitting multi-year highs. In the microcap domain, high asset efficiency means nothing if operational liquidity gets trapped in the balance sheet. Is this business a structural specialty champion in the making, or is it hitting systemic operating constraints?

Section 2 — Introduction

Chembond Chemicals is a specialty chemical producer founded over half a century ago in 1974. For a significant portion of its corporate life, the business operated inside an intricate maze of subsidiaries, joint ventures, and step-down overseas entities that fragmented its financial visibility.

The structural pivot arrived via an NCLT arrangement effective from the previous year, leading to a listing under its consolidated operational banner in July 2025. This process consolidated the core specializations into a highly focused microcap entity. The publication of the audited FY26 results offers the first full-year financial snapshot of the post-demerger layout, clarifying the company’s real earning capacity away from structural transitions.

Section 3 — Business Model: WTF Do They Even Do?

Chembond is effectively an industrial water physician. The company processes, formulates, and supplies specialty chemical solutions that keep industrial infrastructure from corroding, scaling, or choking. It breaks its commercial engine into four key operating divisions:

• Water Technologies: The primary engine contributing a staggering 87% of total revenues. It sells water treatment chemicals, setups filtration/dosing equipment, and runs cloud-based telemetry loops to monitor customer chemical feed rates.
• Construction Chemicals: Contributes 7% of revenue, fabricating admixtures, concrete repair mortars, and sealants.
• Chemical Distribution: Accounts for 6% of sales, serving as an importer and stockist for raw additives.
• Cleaning & Hygiene: A joint venture with German partner Calvatis GmbH, adding a minor 1% to the topline by selling sanitization formulas to the food processing and hospitality industries.

Section 4 — Financials Overview

Figures are consolidated, in ₹ crore.

Quarterly Performance Trend

The sequential revenue acceleration from ₹65.38 crore in Q1 to ₹101.38 crore in Q4 indicates a sharp operational recovery in the second half of the fiscal year. Quarterly volatility is common in business, but a linear structural recovery across consecutive periods points to strong end-user consumption. ### Did Management Walk the Talk? During their November 2025 investor call, management acknowledged a flat first half caused by a prolonged monsoon that damaged high-volume seasonal chemical sales and delayed equipment installation timelines. They pointed to an unexecuted new order book exceeding ₹100 crore in the water segment, promising a sharp recovery as execution normalised.

The